#CognitiveTherapy

A new study highlights mindfulness-based cognitive therapy (MBCT) as a promising option for people who do not fully recover after standard depression treatment. This approach could offer renewed hope for those with lingering depressive symptoms, a challenge that affects up to 30% of individuals with depression worldwide, including many in Thailand.

Depression remains a leading cause of disability globally and in Thailand, where health authorities report millions affected each year. While antidepressants and talking therapies work for many, some patients never fully escape the fog of low mood and exhaustion after treatment. In an English study published in The Conversation, researchers estimate that about one in three people with depression still struggle with symptoms even after completing therapy and medication.

A recent study has shed light on the potential of mindfulness-based cognitive therapy (MBCT) to address a persistent gap in depression care—helping individuals who do not fully recover after standard treatment. This promising approach could offer renewed hope for those living with lingering depressive symptoms, a scenario that affects up to 30% of people diagnosed with depression worldwide, including many in Thailand.

Depression remains a leading cause of disability both globally and in Thailand, where the World Health Organization estimates over 1.5 million Thais suffer from the condition each year (WHO). While effective antidepressants and talking therapies exist, for many patients the journey out of depression is not straightforward. As outlined in a new study conducted in England and published in The Conversation (The Conversation), about one-third of people with depression never fully escape the “fog” of low mood and exhaustion—even after completing therapy and medication.

Recent research sheds light on brain fog, a cluster of cognitive symptoms often linked to chronic illnesses and conditions. While the term surged during the COVID-19 era, many people with long COVID report persistent brain fog. Data suggests a wide range of prevalence among long COVID patients, highlighting the substantial impact on daily life. Beyond COVID, brain fog also appears in conditions like fibromyalgia, chronic fatigue syndrome, and lupus, drawing attention from clinicians and patients worldwide.

Emerging research reveals intriguing insights into the often-debilitating phenomenon known as brain fog, a symptom linked with various chronic illnesses and conditions. As COVID-19 swept the globe, the term “brain fog” gained prominence, particularly among those suffering from long COVID, with estimates suggesting that 20 to 65 percent of these individuals experience it ¹. Beyond its association with COVID, brain fog is also recognized in communities dealing with chronic illnesses such as fibromyalgia, chronic fatigue syndrome, and lupus, attracting interest and concern among healthcare professionals and patients alike.